Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clarivate Analytics Plc (NY: CLVT )

5.760 +0.180 (+3.23%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarivate Analytics Plc

< Previous 1 2 3 4 5 6 7 Next >
Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Generative AI Startup AI21 Labs Reaches Unicorn Status With Latest Funding Round
AI21 Labs, a front-runner in the AI domain specializing in large language models (LLMs), declared the completion of a $155 million Series C fundraiser.  
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Where Clarivate Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
Via Benzinga
What 5 Analyst Ratings Have To Say About Clarivate
Via Benzinga
Where Clarivate Stands With Analysts
Via Benzinga
Analyst Expectations for Clarivate's Future
Via Benzinga
The Latest Analyst Ratings for Clarivate
Via Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Industrials Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Expert Ratings for Clarivate
Via Benzinga
Expert Ratings for Clarivate
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
Where Clarivate Stands With Analysts
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Analyst Ratings for Clarivate
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
5 Analysts Have This to Say About Clarivate
Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
12 Industrials Stocks Moving In Thursday's Intraday Session
Via Benzinga
What 5 Analyst Ratings Have To Say About Clarivate
  Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter: 
Via Benzinga
Recap: Clarivate Q2 Earnings
  Clarivate (NYSE:CLVT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts
Oppenheimer analyst Owen Lau initiates coverage on Clarivate Plc (NYSE: CLVT) with an Outperform rating and  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
Via Benzinga
12 Industrials Stocks Moving In Wednesday's Intraday Session
Via Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 61 companies hit new 52-week lows. 
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know
Morgan Stanley has decided to maintain its Overweight rating of Clarivate (NYSE:CLVT) and lower its price target from $16.00 to $15.00. Shares of Clarivate are trading down 2.75% over the last 24... 
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.